https://www.bswhealth.com/blog/unlocking-power-of-biomarker-testing-cancer-early-detection
Explore how researchers are harnessing the power of biomarker testing for cancer early detection.
the powerunlockingbiomarkertestingcancer
https://pubmed.ncbi.nlm.nih.gov/41301080/
Biomarkers have transformed cancer care by linking molecular insights to personalized treatment strategies. This review first surveys the spectrum of detection...
cancer biomarkerbridgingdiscoverytreatment
https://pubmed.ncbi.nlm.nih.gov/37581094/?dopt=Abstract
Immune infiltrate-associated ZPR1 could be considered a novel negative prognostic biomarker for therapeutic response in HCC.
digital pathologypancancerprofilinganalysis
https://www.news-medical.net/news/20240606/Novel-PET-radiotracer-enables-same-day-imaging-of-gastrointestinal-cancer-biomarker.aspx
A new PET radiotracer enables same-day imaging of the important gastrointestinal cancer biomarker known as Claudin18.2 (CLDN18.2).
pet radiotracergastrointestinal cancernoveldayimaging
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.894744/full
Cancer cells typically exhibit a tightly regulated program of metabolic plasticity and epigenetic remodeling to meet the demand of uncontrolled cell prolifer...
frontiersnicotinamidemethyltransferasebiomarkertarget
https://www.marketresearchfuture.com/reports/cancer-biomarker-market-5378
Cancer Biomarker Market projected to grow at 6.06% CAGR, reaching USD 33.28 Billion by 2035, driving growth global trends, competitive industry analysis and...
cancer biomarkermarket sizesharetrendsreport
https://pubmed.ncbi.nlm.nih.gov/31262886/
Pancreatic cancer cells are sensitive to pharmacologically achievable RX-3117 concentrations and UCK2 might be exploited as a biomarker for patient treatment...
as auridinecytidinekinasepotential
https://pubmed.ncbi.nlm.nih.gov/31975694/?myncbishare=nymclib
Reply to Comment on 'Volatile biomarker in breath predicts lung cancer and pulmonary nodules'
replycommentvolatilebiomarkerbreath
https://case.edu/medicine/about/newsroom/our-latest-news/biomarker-may-predict-which-her2-negative-breast-cancer-patients-will-benefit-targeted-therapy
A multicenter team led by Case Western Reserve has demonstrated that brief exposure to a targeted therapy can tell doctors which HER2-negative patient...
breast cancerbiomarkermaypredictnegative
https://www.sciencedaily.com/releases/2007/08/070815085345.htm
Researchers have identified the first immune molecule that appears to play a role in prostate cancer development and in predicting cancer recurrence and...
prostate cancerfirstbiomarkerdiscoveredoutcome